Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

Gastroenterology

Volumn 149, Issue 7, 2015, Pages 1784-1793

  Loomba, Rohit ^a,b,c   Schork, Nicholas ^d   Chen, Chi Hua ^e   Bettencourt, Ricki ^a   Bhatt, Ana ^a   Ang, Brandon ^a   Nguyen, Phirum ^a   Hernandez, Carolyn ^a   Richards, Lisa ^a   Salotti, Joanie ^a   Lin, Steven ^a   Seki, Ekihiro ^b   Nelson, Karen E ^d   Sirlin, Claude B ^a   Brenner, David ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d J CRAIG VENTER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fatty Liver; Genetic Factors; NAFLD; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLESTEROL; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIZYGOTIC TWINS; ELASTOGRAPHY; ETHNIC DIFFERENCE; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HERITABILITY; HUMAN; INSULIN BLOOD LEVEL; INTERNATIONAL NORMALIZED RATIO; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MONOZYGOTIC TWINS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; AGED; CALIFORNIA; CHI SQUARE DISTRIBUTION; GENETIC PREDISPOSITION; GENETICS; HEREDITY; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHENOTYPE; RISK FACTOR; TWINS;

ADULT; AGED; CALIFORNIA; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 84949959656     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.08.011     Document Type: Article

References (50)

1. N. Chalasani, Z. Younossi, J.E. Lavine, and et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
2. V. Ratziu, S. Bellentani, H. Cortez-Pinto, and et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference J Hepatol 53 2010 372 384
3. R. Loomba, and A.J. Sanyal The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 2013 686 690
4. R.M. Williamson, J.F. Price, S. Glancy, and et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study Diabetes Care 34 2011 1139 1144
5. S. Singh, A.M. Allen, Z. Wang, and et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies Clin Gastroenterol Hepatol 13 2015 643 654 e1-e9; quiz e39-e40
6. M. Ekstedt, H. Hagstrom, P. Nasr, and et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 2015 1547 1554
7. L.A. Adams, J.F. Lymp, J. St Sauver, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
8. P. Angulo, E. Bugianesi, E.S. Bjornsson, and et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 145 2013 782 789 e4
9. N. Bhala, P. Angulo, D. van der Poorten, and et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study Hepatology 54 2011 1208 1216
10. P. Angulo, D.E. Kleiner, S. Dam-Larsen, and et al. Liver fibrosis, but no other histologic features, associates with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 2015
11. R. Loomba, and N. Chalasani The hierarchical model of NAFLD: prognostic significance of histologic features in NASH Gastroenterology 149 2015 278 281
12. S.L. Friedman Liver fibrosis in 2012: convergent pathways that cause hepatic fibrosis in NASH Nat Rev Gastroenterol Hepatol 10 2013 71 72
13. E.K. Speliotes, J.L. Butler, C.D. Palmer, and et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912
14. J. Makkonen, K.H. Pietilainen, A. Rissanen, and et al. Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins J Hepatol 50 2009 1035 1042
15. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, and et al. Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
16. Y.S. Roh, R. Loomba, and E. Seki The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitis Gastroenterology 148 2015 252 254
17. L.E. Wagenknecht, A.L. Scherzinger, E.R. Stamm, and et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort Obesity (Silver Spring) 17 2009 1240 1246
18. M.C. Brouwers, R.M. Cantor, N. Kono, and et al. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia J Lipid Res 47 2006 2799 2807
19. S. Romeo, J. Kozlitina, C. Xing, and et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
20. Y. Rotman, C. Koh, J.M. Zmuda, and et al. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Hepatology 52 2010 894 903
21. R. Loomba, M. Abraham, A. Unalp, and et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis Hepatology 56 2012 943 951
22. R. Loomba, F. Rao, L. Zhang, and et al. Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins Gastroenterology 139 2010 836 845 845 e1
23. B.A. Neuschwander-Tetri, J.M. Clark, N.M. Bass, and et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease Hepatology 52 2010 913 924
24. M. Noureddin, K.P. Yates, I.A. Vaughn, and et al. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients Hepatology 58 2013 1644 1654
25. J. Chen, J.A. Talwalkar, M. Yin, and et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography Radiology 259 2011 749 756
26. R. Loomba, T. Wolfson, B. Ang, and et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study Hepatology 60 2014 1920 1928
27. S.K. Asrani, J.A. Talwalkar, P.S. Kamath, and et al. Role of magnetic resonance elastography in compensated and decompensated liver disease J Hepatol 60 2014 934 939
28. D. Kim, W.R. Kim, J.A. Talwalkar, and et al. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography Radiology 268 2013 411 419
29. J. Cui, B. Ang, W. Haufe, and et al. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study Aliment Pharmacol Ther 41 2015 1271 1280
30. S.C. Lin, E. Heba, T. Wolfson, and et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique Clin Gastroenterol Hepatol 13 2015 1337 1345
31. T.A. Le, J. Chen, C. Changchien, and et al. Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial Hepatology 56 2012 922 932
32. R. Loomba, C.B. Sirlin, B. Ang, and et al. Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial) Hepatology 61 2015 1239 1250
33. A. Zarrinpar, S. Gupta, M.R. Maurya, and et al. Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study Gut 2015 Epub ahead of print
34. N.F. Boyd, G.S. Dite, J. Stone, and et al. Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 347 2002 886 894
35. Z. Permutt, T.A. Le, M.R. Peterson, and et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease-MRI accurately quantifies hepatic steatosis in NAFLD Aliment Pharmacol Ther 36 2012 22 29
36. N.S. Patel, I. Doycheva, M.R. Peterson, and et al. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 13 2015 561 568
37. L. Castera, V. Vilgrain, and P. Angulo Noninvasive evaluation of NAFLD Nat Rev Gastroenterol Hepatol 10 2013 666 675
38. M. Noureddin, J. Lam, M.R. Peterson, and et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials Hepatology 58 2013 1930 1940
39. S.B. Reeder Emerging quantitative magnetic resonance imaging biomarkers of hepatic steatosis Hepatology 58 2013 1877 1880
40. S.B. Reeder, I. Cruite, G. Hamilton, and et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy J Magn Reson Imaging 34 2011 729 749
41. M.E. Rinella, R. Loomba, S.H. Caldwell, and et al. Controversies in the diagnosis and management of NAFLD and NASH Gastroenterol Hepatol (NY) 10 2014 219 227
42. N.G. Martin, L.J. Eaves, M.J. Kearsey, and et al. The power of the classical twin study Heredity (Edinb) 40 1978 97 116
43. K. Tambs, T. Moum, L.J. Eaves, and et al. Genetic and environmental contributions to the variance of body height in a sample of first and second degree relatives Am J Phys Anthropol 88 1992 285 294
44. K.S. Kendler, A.C. Heath, M.C. Neale, and et al. A population-based twin study of alcoholism in women JAMA 268 1992 1877 1882
45. A.D. Tarnoki, D.L. Tarnoki, P. Bata, and et al. Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study Liver Int 32 2012 1287 1293
46. S. Weber, O.A. Gressner, R. Hall, and et al. Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans Clin Liver Dis 12 2008 747 757 vii
47. C.P. Day Genetic studies to identify hepatic fibrosis genes and SNPs in human populations Methods Mol Med 117 2005 315 331
48. J. Bazick, M. Donithan, B.A. Neuschwander-Tetri, and et al. Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD Diabetes Care 38 2015 1347 1355
49. S.A. Harrison, D. Oliver, H.L. Arnold, and et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease Gut 57 2008 1441 1447
50. A. Arulanandan, B. Ang, R. Bettencourt, and et al. Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 13 2015 1513 1520